Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Nasopharyngeal Carcinoma, Mesothelioma, Malignant, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Glioblastoma, Carcinoma, Hepatocellular, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma, Small Cell Lung Carcinoma

NCT03255252 2025-05-18

IMMUVIX

Phase 2 Terminated

29 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT04483544 2025-04-29

Pembrolizumab and Olaparib in Cervical Cancer Patients

Phase 2 Terminated

8 enrolled 13 charts

Gynecologic

Uterine Cervical Neoplasms

NCT03527264 2025-04-04

BrUOG 355: Nivolumab to Tailored Radiation Therapy With Concomitant Cisplatin in the Treatment of Patients With Cervical Cancer

Phase 2 Terminated

4 enrolled 11 charts

Gynecologic

Uterine Cervical Neoplasms

NCT05012397 2024-10-17

Milademetan in Advanced/Metastatic Solid Tumors

Phase 2 Terminated

40 enrolled 13 charts

DermatologicEndocrineGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Testicular Germ Cell Tumor, Adenocarcinoma of Lung, Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Adrenocortical Carcinoma, Cholangiocarcinoma

NCT01284348 2024-08-29

To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung Cancer

Phase 2 Terminated

26 enrolled 18 charts

Classical hematologyGenitourinaryGynecologicHead & NeckThoracic

Anemia, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Small Cell Lung Carcinoma

NCT03439085 2024-07-09

DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers

Phase 2 Terminated

41 enrolled 13 charts

GastrointestinalGenitourinaryGynecologic

Anal Canal Carcinoma, Anus Neoplasms, Uterine Cervical Neoplasms, Neoplasm Metastasis, Neoplasms, Penile Neoplasms, Recurrence, Vaginal Neoplasms, Vulvar Neoplasms

NCT03367871 2024-06-18

Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer

Phase 2 Terminated

17 enrolled 12 charts

Gynecologic

Uterine Cervical Neoplasms

NCT04171700 2023-10-02

LODESTAR

Phase 2 Terminated

83 enrolled 16 charts

BreastGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinosarcoma, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Fallopian Tube Neoplasms, Leiomyosarcoma, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT00794339 2023-08-14

ACRIN6682

Phase 2 Terminated

73 enrolled 19 charts

Gynecologic

Uterine Cervical Neoplasms

NCT04066894 2023-08-14

Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE Study

Phase 2 Terminated

3 enrolled 5 charts

GastrointestinalGenitourinaryGynecologic

Low Anterior Resection Syndrome, Anus Neoplasms, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Pelvic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Uterine Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT03386721 2023-02-21

Basket Study to Evaluate the Therapeutic Activity of Simlukafusp Alfa as a Combination Therapy in Participants With Advanced and/or Metastatic Solid Tumors

Phase 2 Terminated

256 enrolled 26 charts

Gynecologic

Uterine Cervical Neoplasms

NCT04230954 2022-06-07

Cabozantinib Plus Pembrolizumab for Recurrent, Persistent and/or Metastatic Cervical Cancer

Phase 2 Terminated

5 enrolled

Gynecologic

Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Carcinoma, Adenosquamous

NCT00900562 2021-10-28

Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy

Phase 2 Terminated

19 enrolled 21 charts

Gynecologic

Uterine Cervical Neoplasms, Neoplasms, Endometrial Neoplasms

NCT01392352 2020-02-13

HYPAZ

Phase 2 Terminated

31 enrolled

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Gastrointestinal Neoplasms, Glioblastoma, Hypertension, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Small Cell Lung Carcinoma

NCT03852979 2020-01-10

NEOCON-F

Phase 2 Terminated

1 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT00924066 2019-11-21

Ixabepilone to Treat Cervical Cancer

Phase 2 Terminated

41 enrolled 11 charts

Gynecologic

Uterine Cervical Neoplasms

NCT01958112 2019-05-31

GSK1120212+GSK2141795 for Cervical Cancer

Phase 2 Terminated

14 enrolled 10 charts

Gynecologic

Uterine Cervical Neoplasms

NCT02233387 2019-03-08

HX4-cervix

Phase 2 Terminated

4 enrolled

Gynecologic

Hypoxia, Uterine Cervical Neoplasms

NCT02509585 2019-02-11

A Trial of Comparing the Pathology Status of Lymphoseek®-Identified Sentinel Lymph Nodes Relative to the Pathological Pathology Status of Nonsentinel Lymph Nodes in Nodal Staging of Subjects With Known Cancer of the Cervix Who Are Undergoing Lymph Node Dissection

Phase 2 Terminated

18 enrolled 17 charts

Gynecologic

Uterine Cervical Neoplasms

NCT01075412 2017-12-02

FLT PET Imaging for Cervical Cancer

Phase 2 Terminated

6 enrolled 6 charts

Gynecologic

Uterine Cervical Neoplasms

NCT00003525 2017-09-29

Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva

Phase 2 Terminated

8 enrolled

Gynecologic

Uterine Cervical Neoplasms, Vulvar Neoplasms

NCT00312286 2016-09-23

Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.

Phase 2 Terminated

538 enrolled

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections, Atypical Squamous Cells of the Cervix

NCT00590967 2016-08-29

A Phase II Study of Extended Field IMRT External Beam Irradiation and Intracavitary Brachytherapy

Phase 2 Terminated

69 enrolled 6 charts

Gynecologic

Uterine Cervical Neoplasms

NCT02479178 2016-04-14

iNSITE2

Phase 2 Terminated

73 enrolled

GastrointestinalGenitourinaryGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Cholangiocarcinoma

NCT00966992 2015-09-09

Study of Zoledronic Acid Versus Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer

Phase 2 Terminated

3 enrolled 2 charts

Gynecologic

Uterine Cervical Neoplasms

NCT00626561 2014-07-07

Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix

Phase 2 Terminated

4 enrolled 2 charts

Gynecologic

Uterine Cervical Neoplasms, Uterine Neoplasms

NCT00138151 2013-11-20

Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer

Phase 2 Terminated

33 enrolled 6 charts

Gynecologic

Uterine Cervical Neoplasms

NCT00002478 2013-06-10

Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer

Phase 2 Terminated

Gynecologic

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Ovarian Neoplasms

NCT00003624 2013-04-11

Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer

Phase 2 Terminated

GynecologicSarcoma

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Sarcoma, Endometrial Neoplasms, Neurotoxicity Syndromes

NCT00006224 2013-04-11